GF Fund Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.4K Hold
2,488
﹤0.01% 431
2025
Q1
$31.3K Buy
2,488
+447
+22% +$5.62K ﹤0.01% 454
2024
Q4
$21.5K Buy
+2,041
New +$21.5K ﹤0.01% 464